AGP Executive Report
Last update: 11 hours agoDiabetes Access Boost: SAHPRA has approved Sun Pharma to manufacture and market a generic semaglutide injection for adults with inadequately controlled type 2 diabetes, with once-weekly dosing pens expected to launch soon. Maternal Health Alarm: New District Health Barometer figures point to rising newborn deaths in public hospitals and highlight ongoing pressure on maternity care, with maternal deaths in facilities still far from targets. Immunisation Watch: WHO/UNICEF report shows global childhood vaccination coverage is improving again in 2025, but 13.5 million infants still missed routine immunisation entirely. Public Health for Migrants: Legal analysis reiterates that the Constitution protects “everyone”’s right to healthcare and that emergency treatment can’t be refused based on nationality or immigration status. Gauteng Staffing Controversy: Gauteng Health’s R612m foreign healthcare spend is questioned as SA doctors and nurses remain unemployed. Mental Health in Focus: SADAG explains what happens after a first panic attack and offers a practical recovery guide. Water Security Update: Cape Town dam storage edges up to 78.1% as winter rainfall improves reserves. Drug Policy Push: Vusubuntu Coalition calls for decriminalising small amounts of personal drug use, arguing it should be treated as a public health issue.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
![[Latest] Point-Of-Care Molecular Diagnostics Market to Grow Rapidly, Hitting US$ 17.94 Bn by 2034 at 8.70% CAGR, due to Growing Clinical Need for Rapid, Decentralized Genetic Testing for Infectious Disease Decisions, says ZMR](https://ml.globenewswire.com/media/1f4cf0ab-7d76-4136-a6dc-a5545f80f538/small/zion-market-research-jpg.jpg)
